Very exciting data and will still take time, yet hard to imagine long term autologous remains king. So many advantages of allogeneic and now we have evidence of the ability to evade the immune system, things will get very interesting.    
$FATE $CRBU $SANA $IPSC $ALLO $CRSP
#FATE #CRBU #SANA #IPSC #ALLO #CRSP